SCHEMBL3890451

SCHEMBL3890451

C[C@@H](O)[C@H]1OC(C)(C)O[C@@H]1[C@@H](C)O

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HDAC3 O15379 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14234008 1.00 L3MBTL1 (0.43) L3MBTL1HDAC3HDAC1HDAC2
SCHEMBL14944927 0.85 L3MBTL1 (0.38) L3MBTL1
SCHEMBL11476566 0.85 L3MBTL1 (0.38) L3MBTL1
SCHEMBL14944929 0.85 L3MBTL1 (0.38) L3MBTL1
SCHEMBL14944947 0.85 L3MBTL1 (0.38) L3MBTL1
SCHEMBL14944941 0.85 L3MBTL1 (0.38) L3MBTL1
SCHEMBL11477779 0.85 L3MBTL1 (0.38) L3MBTL1
SCHEMBL16883361 0.84 L3MBTL1 (0.35) L3MBTL1
SCHEMBL18263599 0.84 LMNA (0.38) L3MBTL1
SCHEMBL7147304 0.84 LMNA (0.38) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2847185-B1 MACROCYCLIC PICOLINAMIDES AS FUNGICIDES DOW AGROSCIENCES LLC (US) 2016-11-16 — — EP disclosed
US-9144239-B2 Macrocyclic picolinamides as fungicides DOW AGROSCIENCES LLC (US) 2015-09-29 — — US disclosed
US-20140275171-A1 MACROCYCLIC PICOLINAMIDES AS FUNGICIDES DOW AGROSCIENCES LLC 2014-09-18 — — US disclosed
US-8785479-B2 Macrocyclic picolinamides as fungicides DOW AGROSCIENCES, LLC. (US) 2014-07-22 — — US disclosed
US-20130296375-A1 MACROCYCLIC PICOLINAMIDES AS FUNGICIDES DOW AGROSCIENCES LLC (US) 2013-11-07 — — US disclosed
EP-1483273-B1 LIGANDS FOR ASYMMETRIC REACTIONS SOLVIAS AG (CH) 2009-01-07 — — EP disclosed
US-7407910-B2 Ligands for asymmetric reactions SOLVIAS AG (CH) 2008-08-05 — — US disclosed
US-20060241307-A1 Bidentate having a heterocyclic ring, especially benzothiophene, 2,3-disubstituted with phosphonate, phosphine, phosphine oxide, dioxyphosphine or diaminophosphine groups; transition metal complexes; hydrogenation, isomerizatioin, hydroformylation, hydroboration, hydrosilylation or hydrocyanation BERENS ULRICH 2006-10-26 — — US disclosed
US-7094907-B2 Ligands for asymmetric reactions SOLVIAS AG (CH) 2006-08-22 — — US disclosed
US-20040260091-A1 Ligands for asymmetric reactions SOLVIAS AG (CH) 2004-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275171-A1 MACROCYCLIC PICOLINAMIDES AS FUNGICIDES FKBP14, FKBP2, CYP51A1 L3MBTL1 4418/4885HDAC3 357/4885HDAC1 195/4885
US-20060241307-A1 Bidentate having a heterocyclic ring, especially benzothiophene, 2,3-disubstituted with phosphonate, phosphine, phosphine oxide, dioxyphosphine or diaminophosphine groups; transition metal complexes; hydrogenation, isomerizatioin, hydroformylation, hydroboration, hydrosilylation or hydrocyanation NR2E3, WNK2, OXSR1 L3MBTL1 2378/4885HDAC3 2240/4885HDAC1 2518/4885
US-20040260091-A1 Ligands for asymmetric reactions COASY, ICMT, AP2M1 L3MBTL1 4760/4885HDAC3 3397/4885HDAC1 980/4885
US-20130296375-A1 MACROCYCLIC PICOLINAMIDES AS FUNGICIDES FKBP14, FKBP2, CYP51A1 L3MBTL1 4418/4885HDAC3 357/4885HDAC1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback